论文部分内容阅读
ATP临床应用以来,引起过敏性休克之病例报告甚少,现将所见一例报导如下。男,61岁,住院号78785。于1983年4月23日因头晕2天、眩晕8小时入院。并有复视、耳鸣,无恶心、呕吐,无发热。既往有高血压病、冠心病及脑动脉硬化病史。有青霉素过敏史。体查:血压150/100,左侧眼裂较右侧略小,伸舌居中,双侧巴彬斯基氏征可疑阳性,肢体活动自如。脑血流图示脑动脉硬化。诊断椎基底动脉硬化、短暂性脑缺血。除按常规处理外,加用肌注ATP 40mg,每日一次。用药2天后,头晕、眩晕、复视、耳鸣症状有所改善。但是在第3次注射ATP约1分钟后,病人即述注射部位显著
Since the clinical application of ATP, few reports of cases of anaphylactic shock have been reported, as one of the examples reported below. Male, 61 years old, hospital number 78785. April 23, 1983 because of dizziness 2 days, dizziness 8 hours admission. And diplopia, tinnitus, no nausea, vomiting, no fever. Past history of hypertension, coronary heart disease and cerebral arteriosclerosis. Have a history of penicillin allergy. Physical examination: blood pressure 150/100, the left scrotum is slightly smaller than the right, extensor middle, bilateral Babinski’s syndrome suspicious positive, limb activity freely. Cerebral blood flow shows cerebral arteriosclerosis. Diagnosis of vertebrobasilar artery sclerosis, transient cerebral ischemia. In addition to conventional treatment, plus intramuscular ATP 40mg, once daily. Two days after treatment, dizziness, dizziness, diplopia, tinnitus symptoms improved. However, after the third injection of ATP for about 1 minute, the patient noted the site of injection